Publicacións nas que colabora con Carlos Spuch Calvar (11)

2022

  1. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

  2. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

2021

  1. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

    Annals of Medicine, Vol. 53, Núm. 1, pp. 43-69

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  3. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: A peripheral biomarker in the etiology of schizophrenia

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

    Frontiers in Psychology, Vol. 12

2020

  1. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

    Frontiers in Pharmacology, Vol. 11

  2. Mania as Debut of Cushing's Syndrome

    Case Reports in Psychiatry, Vol. 2020

2019

  1. Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways

    Frontiers in Psychiatry, Vol. 10

2018

  1. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis

    Journal of Psychiatric Research, Vol. 106, pp. 43-53

  2. The role of the gut microbiota in schizophrenia: Current and future perspectives

    World Journal of Biological Psychiatry, Vol. 19, Núm. 8, pp. 571-585